Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The next generation of exoskeletons: lighter, cheaper devices are in the works.
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Simvastatin in acute optic neuritis.
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
[Sexuality of men with neurologic disorders].
Mast cells: an expanding pathophysiological role from allergy to other disorders.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
Multiple sclerosis.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
Enrollment complete for cannabinoid MS study
Natalizumab to fingolimod washout in patients at risk of PML: When good intentions yield bad outcomes.
Coping strategies and mood profiles in patients with multiple sclerosis.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.

Pages